Candesartan cilexetil/Hydrochloorthiazide ratiopharm (Candesartan)
Candesartan cilexetil/Hydrochloorthiazide ratiopharm (Candesartan) Uses, Dosage, Side Effects, Food Interaction and all others data.
Candesartan cilexetil/Hydrochloorthiazide ratiopharm (Candesartan) is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. It is available as a prodrug in the form of candesartan cilexetil.
Table Of contents
Trade Name | Candesartan cilexetil/Hydrochloorthiazide ratiopharm (Candesartan) |
Availability | Prescription only |
Generic | Candesartan |
Candesartan Other Names | Candesartan |
Related Drugs | amlodipine, lisinopril, metoprolol, losartan, furosemide, carvedilol, hydrochlorothiazide, spironolactone |
Type | |
Formula | C24H20N6O3 |
Weight | Average: 440.454 Monoisotopic: 440.159688536 |
Groups | Experimental |
Therapeutic Class | |
Manufacturer | |
Available Country | Netherlands |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Candesartan cilexetil/Hydrochloorthiazide ratiopharm (Candesartan) is an angiotensin-receptor blocker indicated in the treatment of hypertension.
Candesartan cilexetil/Hydrochloorthiazide ratiopharm (Candesartan) is also used to associated treatment for these conditions: High Blood Pressure (Hypertension), NYHA Functional Class II-IV Heart Failure
Food Interaction
[Moderate] GENERALLY AVOID: Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).
ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.
Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.
MANAGEMENT: Patients should receive dietary counseling and be advised to not use potassium-containing salt substitutes or over-the-counter potassium supplements without consulting their physician.
If salt substitutes are used concurrently, regular monitoring of serum potassium levels is recommended.
Patients should also be advised to seek medical attention if they experience symptoms of hyperkalemia such as weakness, irregular heartbeat, confusion, tingling of the extremities, or feelings of heaviness in the legs.
Candesartan cilexetil/Hydrochloorthiazide ratiopharm (Candesartan) Drug Interaction
Moderate: aspirin, aspirin, pregabalin, pregabalinUnknown: rosuvastatin, rosuvastatin, omega-3 polyunsaturated fatty acids, omega-3 polyunsaturated fatty acids, atorvastatin, atorvastatin, acetaminophen, acetaminophen, levothyroxine, levothyroxine, cyanocobalamin, cyanocobalamin, ascorbic acid, ascorbic acid, cholecalciferol, cholecalciferol
Candesartan cilexetil/Hydrochloorthiazide ratiopharm (Candesartan) Disease Interaction
Major: diabetes, angioedema, hypotensionModerate: CHF, hyperkalemia, renal artery stenosis, renal impairment, renal/liver disease
Innovators Monograph
You find simplified version here Candesartan cilexetil/Hydrochloorthiazide ratiopharm (Candesartan)